Companies: 10,795·Total market cap: $144.5T
National Health Investors, Inc.

National Health Investors, Inc.

NHINYSEReal Estate● Active
$69.66
$-0.77(-1.09%)
Market Cap$3.4B
P/E Ratio
52W High$91.38
52W Low$68.47

National Health Investors, Inc. (NHI) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

nhi · stock forecast · 18 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 18 Wall Street analysts in the past 3 months

SellBuy

Hold

18 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
6
Hold
11
Sell
1
Strong Sell
0
Total: 18 · Buy rate: 33.3%

12-Month Price Target

High

$86.00

Consensus

$84.75

+21.8% upside

Low

$83.00

Median: $85 · Last Close: $69.56

The National Health Investors, Inc. (NHI) analyst consensus is Hold, based on ratings from 18 Wall Street analysts over the past 3 months. The average 12-month NHI price target is $84.75, representing +21.8% upside from the current price of $69.56.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $85 (21.8%)

Consensus Target

$84.75

21.8% upside

High Target

$86

23.6%

Low Target

$83

19.3%

Current Price

$69.56

as of today

Based on analyst price targets, the NHI stock price prediction for the next 12 months ranges from $83 to $86. The consensus NHI price forecast of $84.75 implies 21.8% upside from the current price of $69.56.

Short-Term Price Prediction

Bear

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$66.544.34%

1-day model range: $66.3–$66.79. Peak: $66.79 (-4.34%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$85+21.6%
2028$96+37.3%
2029$103+47.9%
2030$108+54.8%
2031+59.2%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

7%0%93%
1Buy
0Neutral
13Sell
RSI (14)28.2Oversold
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · NHI · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$69.79SELL
MA 10$72.05SELL
MA 20$73.79SELL
MA 50$77.89SELL
MA 100$81.11SELL
MA 200$79.15SELL
Current $NHI · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$70.23SELL
EMA 10$71.54SELL
EMA 20$73.33SELL
EMA 50$76.66SELL
EMA 100$78.51SELL
EMA 200$78.29SELL
Current $NHI · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Wells Fargo2026-06-01
Maintains
Equal WeightEqual Weight
Wells Fargo2026-04-22
Maintains
Equal WeightEqual Weight
Cantor Fitzgerald2026-04-22
Maintains
OverweightOverweight
Truist Securities2026-04-22
Maintains
BuyBuy
Wells Fargo2026-03-27
Maintains
Equal WeightEqual Weight
Truist Securities2026-03-12
Maintains
BuyBuy
Truist Securities2025-12-16
Maintains
BuyBuy
Keybanc2025-12-04
Maintains
OverweightOverweight
Wells Fargo2025-11-25
Maintains
Equal WeightEqual Weight
Wells Fargo2025-08-27
Maintains
Equal WeightEqual Weight

Wall Street analysts have recently issued updated ratings on National Health Investors, Inc. (NHI) stock. Of the recent 77 rating actions, 14 were upgrades and 12 were downgrades. 18 analysts currently cover NHI.

Analyst Recommendation Trends

Buy ratings101
Hold ratings11
Sell ratings00

NHI analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$280M

↑ 2.2% YoY

Revenue Next Year

$279M

↓ 0.1% YoY

EPS This Year

$3.56

EPS Next Year

$3.44

↓ 3.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast NHI EPS of $3.56 for the current fiscal year, based on estimates from 3 analysts. The NHI revenue forecast is $280M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The NHI stock forecast is supported by two independent data sources: analyst consensus ratings from 18 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus NHI price target is $84.75 (+21.8% upside), with an analyst consensus of Hold.

The NHI short-term stock prediction for tomorrow is $66.54 (-4.34%). The NHI stock price prediction for 2027 estimates an average of $85. The NHI stock prediction for 2030 projects a range of $104–$111.

National Health Investors, Inc. trades on NYSE under the ticker NHI. The NHI stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 33% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

NHI forecast · 8 questions

According to 18 Wall Street analysts, the average 12-month NHI price target is $84.75, with a high forecast of $86.00 and a low of $83.00. The median price target is shown in the chart above when available. This implies +21.8% potential upside from the current price of $69.56.

NHI price targetWhat is NHI price targetNHI analyst price targetNHI 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.